Difficulty: Medium
Average Score: 72%
Practice
All of the following agents are the first-line antimycobacterial drugs, EXCEPT:
Correct answer
D
Rationale
In the context of safety pharmacology across the lifespan, understanding the first-line antimycobacterial drugs is crucial for effective patient care. The correct answer is D) Streptomycin. Streptomycin is not typically considered a first-line antimycobacterial drug due to its potential for serious side effects, such as ototoxicity and nephrotoxicity. It is often reserved for cases of multidrug-resistant tuberculosis.
A) Rifampin is a first-line antimycobacterial drug commonly used in the treatment of tuberculosis due to its effectiveness and relatively low toxicity profile.
B) Pyrazinamide is another first-line antimycobacterial drug that is part of the standard treatment regimen for tuberculosis. It is particularly effective against dormant mycobacteria.
C) Isoniazid is also a first-line antimycobacterial drug widely used in the treatment of tuberculosis. It is known for its potency against Mycobacterium tuberculosis and is a key component of tuberculosis treatment regimens.
Educationally, knowing the appropriate first-line antimycobacterial drugs is essential for healthcare providers to make informed decisions regarding the treatment of tuberculosis. Understanding the rationale behind why certain drugs are preferred over others based on efficacy, safety profiles, and resistance patterns is crucial for optimizing patient outcomes and minimizing adverse effects.
A) Rifampin is a first-line antimycobacterial drug commonly used in the treatment of tuberculosis due to its effectiveness and relatively low toxicity profile.
B) Pyrazinamide is another first-line antimycobacterial drug that is part of the standard treatment regimen for tuberculosis. It is particularly effective against dormant mycobacteria.
C) Isoniazid is also a first-line antimycobacterial drug widely used in the treatment of tuberculosis. It is known for its potency against Mycobacterium tuberculosis and is a key component of tuberculosis treatment regimens.
Educationally, knowing the appropriate first-line antimycobacterial drugs is essential for healthcare providers to make informed decisions regarding the treatment of tuberculosis. Understanding the rationale behind why certain drugs are preferred over others based on efficacy, safety profiles, and resistance patterns is crucial for optimizing patient outcomes and minimizing adverse effects.